AgroFresh Solutions (AGFS) 10-Q 9 Nov 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Oct. 26, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-36316
Entity Registrant Name	AgroFresh Solutions, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-4007249
Entity Address, Address Line One	One Washington Square
Entity Address, Address Line Two	510-530 Walnut Street, Suite 1350
Entity Address, City or Town	Philadelphia
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19106
City Area Code	267
Local Phone Number	317-9139
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	AGFS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		53,043,851
Entity Central Index Key	0001592016
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 35,647	$ 61,930
Accounts receivable, net of allowance for doubtful accounts of $1,825 and $2,143, respectively	60,491	53,538
Inventories	24,757	19,780
Other current assets	23,193	19,878
Total Current Assets	144,088	155,126
Property and equipment, net	10,968	11,986
Intangible assets, net	514,128	546,652
Deferred income tax assets	8,445	7,392
Other assets	11,302	11,406
TOTAL ASSETS	688,931	732,562
Current Liabilities:
Accounts payable	12,382	16,969
Current portion of long-term debt	3,139	3,362
Income taxes payable	2,999	2,382
Accrued expenses and other current liabilities	30,925	26,994
Total Current Liabilities	49,445	49,707
Long-term debt	253,240	254,194
Other noncurrent liabilities	7,061	6,256
Deferred income tax liabilities	31,933	34,833
Total Liabilities	341,679	344,990
Commitments and contingencies (see Note 20)
Temporary Equity:
Series B convertible preferred stock, par value $0.0001; 150 shares authorized and designated and 145 shares outstanding at September 30, 2022 and December 31, 2021, respectively	158,398	149,386
Redeemable non-controlling interest	6,877	7,787
Stockholders’ Equity:
Common stock, par value $0.0001; 400,000 shares authorized, 53,705 and 53,080 shares issued and 53,044 and 52,418 outstanding at September 30, 2022 and December 31, 2021, respectively	5	5
Preferred stock, par value $0.0001; 0.001 share authorized and outstanding at September 30, 2022 and December 31, 2021	0	0
Treasury stock, par value $0.0001; 661 shares at September 30, 2022 and December 31, 2021	(3,885)	(3,885)
Additional paid-in capital	512,645	529,303
Accumulated deficit	(273,901)	(248,660)
Accumulated other comprehensive loss	(52,887)	(46,364)
Total Stockholders' Equity	181,977	230,399
TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY	$ 688,931	$ 732,562

UNAUDITED CONDENSED CONSOLIDA_2

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Allowance for doubtful accounts	$ 1,825	$ 2,143
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	53,705,000	53,080,000
Common stock, shares outstanding (in shares)	53,044,000	52,418,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1	1
Preferred stock, shares outstanding (in shares)	1	1
Series B Convertible Stock
Series B convertible preferred stock par value (in dollars per share)	$ 0.0001	$ 0.0001
Series B convertible preferred stock, shares authorized (in shares)	150,000	150,000
Series B convertible preferred stock, shares issued (in shares)	150,000	150,000
Series B convertible preferred stock, shares outstanding (in shares)	145,000	145,000
Treasury Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Treasury stock (in shares)	661,000	661,000

UNAUDITED CONDENSED CONSOLIDA_3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Net sales	$ 47,764	$ 49,178	$ 113,405	$ 110,094
Cost of sales (excluding amortization, shown separately below)	15,552	15,035	36,767	32,453
Gross profit	32,212	34,143	76,638	77,641
Research and development expenses	3,150	3,329	9,085	10,123
Selling, general and administrative expenses	13,537	12,282	39,763	39,453
Amortization of intangibles	10,606	10,830	32,032	32,092
Operating income (loss)	4,919	7,702	(4,242)	(4,027)
Other (expense) income	(35)	(299)	479	14,053
(Loss) gain on foreign currency exchange	(3,299)	(918)	(9,373)	436
Interest expense, net	(5,664)	(5,465)	(15,703)	(16,571)
(Loss) income before income taxes	(4,079)	1,020	(28,839)	(6,109)
Income taxes expense (benefit)	535	208	(2,687)	2,175
Net (loss) income including non-controlling interest	(4,614)	812	(26,152)	(8,284)
Less: Net loss attributable to non-controlling interests	(476)	(182)	(911)	(441)
Net (loss) income attributable to AgroFresh Solutions, Inc.	(4,138)	994	(25,241)	(7,843)
Less: Dividends on convertible preferred stock	6,663	6,248	19,632	18,580
Net loss attributable to AgroFresh Solutions, Inc. common stockholders	$ (10,801)	$ (5,254)	$ (44,873)	$ (26,423)
Loss per share of common shares:
Basic (in dollars per share)	$ (0.21)	$ (0.10)	$ (0.86)	$ (0.51)
Diluted (in dollars per share)	$ (0.21)	$ (0.10)	$ (0.86)	$ (0.51)
Weighted average shares of common stock outstanding:
Basic (in shares)	52,400	51,583	52,077	51,323
Diluted (in shares)	52,400	51,583	52,077	51,323

UNAUDITED CONDENSED CONSOLIDA_4

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (4,614)	$ 812	$ (26,152)	$ (8,284)
Other comprehensive loss
Foreign currency translation adjustments	(5,298)	(2,413)	(6,523)	(8,570)
Comprehensive loss, net of tax	$ (9,912)	$ (1,601)	$ (32,675)	$ (16,854)

UNAUDITED CONDENSED CONSOLIDA_5

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020		0	53,092
Beginning balance (in USD) at Dec. 31, 2020	$ 272,393	$ 0	$ 5	$ (3,885)	$ 552,776	$ (244,836)	$ (31,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,031				2,031
Issuance of stock, net of forfeitures (in shares)			(53)
Shares withheld for taxes (in shares)			(131)
Shares withheld for taxes	(287)				(287)
Issuance of common stock under employee stock purchase plan (in shares)			92
Issuance of common stock under employee stock purchase plan	163				163
Convertible preferred dividend and accretion	(18,580)				(18,580)
Adjustment of NCI to redemption value	0				(491)	491
Net loss attributable to AgroFresh Solutions, Inc.	(7,843)					(7,843)
Comprehensive loss	(8,570)						(8,570)
Ending balance (in shares) at Sep. 30, 2021		0	53,000
Ending balance (in USD) at Sep. 30, 2021	239,307	$ 0	$ 5	(3,885)	535,612	(252,188)	(40,237)
Beginning balance (in shares) at Jun. 30, 2021		0	52,806
Beginning balance (in USD) at Jun. 30, 2021	246,046	$ 0	$ 5	(3,885)	541,185	(253,435)	(37,824)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	949				949
Issuance of stock, net of forfeitures (in shares)			204
Shares withheld for taxes (in shares)			(10)
Shares withheld for taxes	(21)				(21)
Convertible preferred dividend and accretion	(6,248)				(6,248)
Adjustment of NCI to redemption value	0				(253)	253
Net loss attributable to AgroFresh Solutions, Inc.	994					994
Comprehensive loss	(2,413)						(2,413)
Ending balance (in shares) at Sep. 30, 2021		0	53,000
Ending balance (in USD) at Sep. 30, 2021	239,307	$ 0	$ 5	(3,885)	535,612	(252,188)	(40,237)
Beginning balance (in shares) at Dec. 31, 2021		0	53,080
Beginning balance (in USD) at Dec. 31, 2021	230,399	$ 0	$ 5	(3,885)	529,303	(248,660)	(46,364)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	3,228				3,228
Issuance of stock, net of forfeitures (in shares)			741
Shares withheld for taxes (in shares)			(116)
Shares withheld for taxes	(400)				(400)
Issuance of common stock under employee stock purchase plan	146				146
Convertible preferred dividend and accretion	(19,632)				(19,632)
Net loss attributable to AgroFresh Solutions, Inc.	(25,241)					(25,241)
Comprehensive loss	(6,523)						(6,523)
Ending balance (in shares) at Sep. 30, 2022		0	53,705
Ending balance (in USD) at Sep. 30, 2022	181,977	$ 0	$ 5	(3,885)	512,645	(273,901)	(52,887)
Beginning balance (in shares) at Jun. 30, 2022		0	53,354
Beginning balance (in USD) at Jun. 30, 2022	197,090	$ 0	$ 5	(3,885)	518,322	(269,763)	(47,589)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	986				986
Issuance of stock, net of forfeitures (in shares)			351
Convertible preferred dividend and accretion	(6,663)				(6,663)
Net loss attributable to AgroFresh Solutions, Inc.	(4,138)					(4,138)
Comprehensive loss	(5,298)						(5,298)
Ending balance (in shares) at Sep. 30, 2022		0	53,705
Ending balance (in USD) at Sep. 30, 2022	$ 181,977	$ 0	$ 5	$ (3,885)	$ 512,645	$ (273,901)	$ (52,887)

UNAUDITED CONDENSED CONSOLIDA_6

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (26,152)	$ (8,284)
Adjustments to reconcile net loss to net cash provided in operating activities:
Depreciation and amortization	34,252	34,122
Stock-based compensation	3,286	2,031
Amortization of deferred financing costs	1,576	1,772
Deferred income taxes	(4,282)	1,198
Provision for bad debts	472	216
(Gain) loss on sales of property and equipment	(50)	55
Changes in operating assets and liabilities:
Accounts receivable	(1,925)	906
Inventories	(7,356)	2,322
Prepaid expenses and other current assets	(6,774)	(7,799)
Accounts payable	(3,098)	(4,443)
Accrued expenses and other liabilities	6,515	3,103
Income taxes payable	617	(40)
Other assets and liabilities	98	801
Net cash (used in) provided by operating activities	(2,821)	25,960
Cash flows from investing activities:
Capital expenditures	(2,622)	(2,894)
Net cash used in investing activities	(2,622)	(2,894)
Cash flows from financing activities:
Repayment of long-term debt	(2,473)	(11,581)
Payment of preferred dividends	(10,621)	(9,970)
Payment for redemption of convertible preferred stock	0	(5,330)
Proceeds from issuance of stock under employee stock purchase plan	146	163
Net cash used in financing activities	(12,948)	(26,718)
Effect of exchange rate changes on cash and cash equivalents	(7,892)	(3,056)
Net decrease in cash and cash equivalents	(26,283)	(6,708)
Cash and cash equivalents, beginning of period	61,930	50,030
Cash and cash equivalents, end of period	35,647	43,322
Cash paid for:
Cash paid for interest	15,295	14,822
Cash paid for income taxes	2,795	4,560
Supplemental schedule of non-cash investing and financing activities:
Accrued purchases of property and equipment	$ 244	$ 116

Description of Business

Description of Business	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business AgroFresh Solutions, Inc. (the “Company”) is an agriculture technology innovator and global leader with a mission to prevent food loss and waste and conserve the planet’s resources by providing a range of science-based solutions, data-driven digital technologies and high-touch customer services. The Company supports growers, packers and retailers with solutions across the food supply chain to enhance the quality and extend the shelf life of fresh produce. The Company has 40 years of post-harvest experience across a broad range of crops, including revolutionizing the apple industry with the SmartFresh™ Quality System more than 20 years ago. The AgroFresh platform is powered by the Company's comprehensive portfolio that includes plant-based coatings, equipment and proprietary solutions that help improve the freshness supply chain from harvest to the home. The Company has an extensive portfolio of solutions to extend freshness across the produce supply chain from near-harvest up to the point-of sale. These include Harvista™ for near-harvest optimization, and the SmartFresh™ Quality System, the Company's flagship post-harvest freshness solutions. Additional post-harvest freshness solutions include fungicides that can be applied to meet various customer operational requirements in both foggable (ActiMist™) and liquid (ActiSeal™) delivery options. The Company has a controlling interest in AgroFresh Fruit Protection S.A. ("AgroFresh Fruit Protection") (formerly Tecnidex Fruit Protection, S.A.), a leading regional provider of post-harvest fungicides, disinfectants, coatings and packinghouse equipment for the citrus market. Beyond apples and pears, SmartFresh technology can provide ready-to-eat freshness for other fruits and vegetables including avocados, bananas, melons, tomatoes, broccoli and mangos. The Company has key products registered in approximately 50 countries, and supports customers by protecting over 25,000 storage rooms globally. The end-markets that the Company serves are seasonal and are generally aligned with the seasonal growing patterns of the Company’s customers. For those customers growing, harvesting or storing apples and pears, the Company’s core crops, the peak season in the southern hemisphere is the first and second quarters of each year, while the peak season in the northern hemisphere is the third and fourth quarters of each year. Within each half-year period (i.e., January through June for the southern hemisphere, and July through December for the northern hemisphere) the growing season has historically occurred during both quarters. A variety of factors, including weather, may affect the timing of the growing, harvesting and storing patterns of the Company’s customers and therefore shift the consumption of the Company’s services and products between the first and second quarters primarily in the southern hemisphere or between the third and fourth quarters primarily in the northern hemisphere.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. For additional information, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2021. Certain prior period amounts have been reclassified to conform to the current year presentation. COVID-19 The global health crisis caused by COVID-19 and the related government actions and stay at home orders have negatively impacted economic activity and increased political instability across the globe. The outbreak could have a continued material adverse impact on economic and market conditions and trigger a period of global economic slowdown. There have been numerous obstacles presented and some localized financial impacts of the pandemic, including fluctuations in customer demand and spending pattern changes. During the nine months ended September 30, 2022, the COVID-19 pandemic did not have a significant adverse impact on the Company’s results of operations. While the Company is following the requirements of governmental authorities and taking additional preventative and protective measures to ensure the safety of its workforce, including remote working arrangements and varying procedures for essential workforce, the outbreak presents some uncertainty and risk with respect to the Company and its performance and financial results. Adoption of Highly Inflationary Accounting in Argentina and Turkey GAAP requires the use of highly inflationary accounting for countries whose cumulative three-year inflation rate exceeds 100 percent. The Company closely monitors the inflation data and currency volatility where there are multiple data sources for measuring and reporting inflation in applicable countries. In the second quarter of 2018, the Argentine peso rapidly devalued relative to the U.S. dollar, which along with increased inflation, indicated that the three-year cumulative inflation rate in that country exceeded 100 percent as of June 30, 2018. As a result, the Company elected to adopt highly inflationary accounting as of July 1, 2018 for its subsidiary in Argentina. As the three-year cumulative inflation rate exceeded 100 percent as of September 30, 2022, there is no change to highly inflationary accounting in Argentina. In the first half of 2022, the Turkish lira rapidly devalued relative to the U.S. dollar, which along with increased inflation, indicated that the three-year cumulative inflation rate in that country exceeded 100 percent as of April 1, 2022. As a result, the Company elected to adopt highly inflationary accounting as of April 1, 2022 for its subsidiary in Turkey. Under highly inflationary accounting, the functional currencies of the Company's subsidiaries in Argentina and Turkey became the U.S. dollar, and its income statement and balance sheet will be measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates in the currencies of these countries on monetary assets and liabilities are reflected in earnings. As of September 30, 2022, the Company’s subsidiary in Argentina had net assets of ($11.3) million. Net sales attributable to Argentina were approximately 5% and 5% of the Company’s consolidated net sales for the nine months ended September 30, 2022 and 2021, respectively. As of September 30, 2022, the Company’s subsidiary in Turkey had net assets of $11.0 million. Net sales attributable to Turkey were approximately 2% of the Company’s consolidated net sales for the nine months ended September 30, 2022. Disaggregation of Revenue The Company disaggregates revenue from contracts with customers into geographic region, product and timing of transfer of goods and services. The Company determined that disaggregating revenue into these categories achieves the disclosure objective of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues for the three months ended September 30, 2022 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $14,592 $24,344 $861 $1,963 $41,760 Fungicides, disinfectants and coatings 371 2,603 669 — 3,643 Other* 193 1,392 743 33 2,361 $15,156 $28,339 $2,273 $1,996 $47,764 Pattern of Revenue Recognition Products transferred at a point in time $15,033 $28,196 $2,089 $1,933 $47,251 Services transferred over time 123 143 184 63 513 $15,156 $28,339 $2,273 $1,996 $47,764 Revenues for the three months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,677 $23,286 $781 $1,569 $43,313 Fungicides, disinfectants and coatings 917 3,182 1,283 — 5,382 Other* 127 129 180 47 483 $18,721 $26,597 $2,244 $1,616 $49,178 Pattern of Revenue Recognition Products transferred at a point in time $18,603 $26,468 $2,064 $1,583 $48,718 Services transferred over time 118 129 180 33 460 $18,721 $26,597 $2,244 $1,616 $49,178 Revenues for the nine months ended September 30, 2022 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,727 $36,149 $23,901 $13,885 $91,662 Fungicides, disinfectants and coatings 371 12,961 4,493 93 17,918 Other* 509 1,790 1,226 300 3,825 $18,607 $50,900 $29,620 $14,278 $113,405 Pattern of Revenue Recognition Products transferred at a point in time $18,231 $50,217 $29,093 $14,094 $111,635 Services transferred over time 376 683 527 184 1,770 $18,607 $50,900 $29,620 $14,278 $113,405 Revenues for the nine months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $20,020 $34,083 $25,145 $12,745 $91,993 Fungicides, disinfectants and coatings 931 11,044 3,829 — 15,804 Other* 519 602 981 195 2,297 $21,470 $45,729 $29,955 $12,940 $110,094 Pattern of Revenue Recognition Products transferred at a point in time $20,958 $45,131 $29,416 $12,774 $108,279 Services transferred over time 512 598 539 166 1,815 $21,470 $45,729 $29,955 $12,940 $110,094 *Other includes FreshCloud, technical services and sales-type equipment leases related to AgroFresh Fruit Protection. (1) North America includes the United States and Canada. (2) EMEA includes Europe, the Middle East and Africa. (3) Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru and Uruguay. (4) Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan and Thailand. Contract Assets and Liabilities Accounting Standards Codification ("ASC") 606 Revenue from contracts with Customers requires an entity to present a revenue contract as a contract asset when the entity performs its obligations under the contract by transferring goods or services to a customer before the customer pays consideration or before payment is due. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g., receivable), before the entity transfers a good or service to the customer. The following table presents changes in the Company’s contract assets and liabilities during the nine months ended September 30, 2022 and the year ended December 31, 2021: (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $795 12,609 (10,342) $3,062 Contract liabilities: Deferred revenue $635 4,658 (3,688) 1,605 (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $1,484 17,617 (18,306) $795 Contract liabilities: Deferred revenue $1,474 4,123 (4,962) $635 The Company recognizes contract assets in the form of unbilled revenue in instances where services are performed by the Company but not billed by period end. The Company recognizes contract liabilities in the form of deferred revenue in instances where a customer pays in advance for future services to be performed by the Company. The Company generally receives payments from its customers based on standard terms and conditions. No significant changes or impairment losses occurred to contract balances during the nine months ended September 30, 2022. Amounts reclassified from unbilled revenue to accounts receivable for the nine months ended September 30, 2022 and for the year ended December 31, 2021 were $10.3 million and $18.3 million, respectively. Amounts reclassified from deferred revenue to revenue for the nine months ended September 30, 2022 and for the year ended December 31, 2021 were $3.7 million and $5.0 million, respectively. Recently Issued Accounting Standards and Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . The amendments simplify the accounting for income taxes by removing certain exceptions to the general principles of Topic 740, "Income Taxes" and also improve consistent application by clarifying and amending existing guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted the new guidance on January 1, 2021. The adoption of the new guidance did not have a material impact on the condensed consolidated financial statements of the Company. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The amendments provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments are intended to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. The new standard is effective on a date selected by the Company between March 12, 2020 and December 31, 2022. The Company is currently evaluating the impact of adopting this guidance.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions On June 13, 2020, in connection with the execution of the Investment Agreement (as defined in Note 15 - Series B Convertible Preferred Stock and Stockholders’ Equity), the Company, PSP AGFS Holdings, L.P. (“PSP”) and Rohm and Haas Company ("R&H") entered into a side agreement, pursuant to which the parties agreed that if PSP or its affiliates has the right to designate at least 50% of the total directors on the Company’s board of directors pursuant to the Investment Agreement, so long as R&H or its affiliates beneficially owns at least 20% of the Company’s outstanding common stock (on a fully diluted, “as converted” basis), the Company and the board of directors will increase the size of the board of directors by one member and the board will elect a designee selected by R&H to fill the newly-created vacancy. Such right is in addition to any right that R&H has to appoint a member of the board pursuant to its ownership of the Company’s Series A preferred stock (see Note 15 - Series B Convertible Preferred Stock and Stockholders’ Equity). During 2016, the Company made a minority investment in RipeLocker, LLC ("RipeLocker"), a company led by George Lobisser who was formerly a director of the Company. In February 2019, the Company made a further minority investment in RipeLocker. As of and for the nine months ended September 30, 2022, there were no material amounts paid or owed to RipeLocker or Mr. Lobisser. Mr. Lobisser resigned as a director of the Company on February 18, 2021.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Raw material $3,609 $2,726 Work-in-process 4,071 3,746 Finished goods 16,187 12,520 Supplies 890 788 Total inventories $24,757 $19,780

Other Current Assets

Other Current Assets	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Current Assets	Other Current Assets The Company's other current assets at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 VAT receivable $11,547 $10,220 Prepaid income tax asset 7,991 6,256 Prepaid and other current assets 3,655 3,402 Total other current assets $23,193 $19,878

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands, except for useful life data) Useful life September 30, 2022 December 31, 2021 Buildings and leasehold improvements 7-20 $6,766 $6,967 Machinery & equipment 1-12 14,434 13,158 Furniture 1-12 2,797 2,927 Construction in progress 1,230 1,780 25,227 24,832 Less: accumulated depreciation (14,259) (12,846) Total property and equipment, net $10,968 $11,986 Depreciation expense was $0.8 million and $0.7 million for the three months ended September 30, 2022 and 2021, respectively and $2.2 million and $2.0 million for the nine months ended September 30, 2022 and 2021, respectively. Depreciation expense is recorded in cost of sales, selling, general and administrative expense and research and development expense in the unaudited condensed consolidated statements of operations.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Changes in the carrying amount of goodwill for the year ended December 31, 2021 were as follows: (in thousands) December 31, 2021 Beginning balance $6,925 Foreign currency translation (545) Impairment of goodwill (6,380) Ending balance $— As a result of the operating segment realignment discussed in Note 19 - Segment Information, the composition of the Company's reporting units for the evaluation of goodwill impairment has changed. Historically, the Company's reporting units were identified at the operating segment level, which consisted of AgroFresh Core and AgroFresh Fruit Protection and all of the Company's goodwill was assigned to the AgroFresh Fruit Protection reporting unit. Effective December 31, 2021, the Company concluded that it has one operating segment and one reporting unit, which resulted in the reassignment of its goodwill to its stand-alone reporting unit. Prior to the change, the Company tested goodwill for impairment at the previous reporting unit, which did not result in any impairment charge. Based upon the Company's impairment assessment at the new reporting unit (consolidated AgroFresh), the Company determined the carrying amount of the consolidated entity exceeded its fair value. As a result, the Company recorded $6.4 million in goodwill impairment charges during the year ended December 31, 2021. The Company’s intangible assets at September 30, 2022 and December 31, 2021 consisted of the following: September 30, 2022 December 31, 2021 (in thousands) Gross Carrying Accumulated Net Gross Carrying Accumulated Net Intangible assets with finite lives: Developed technology $798,330 ($323,142) $475,188 $798,669 ($293,920) $504,749 Customer relationships 18,122 (7,281) 10,841 19,778 (6,948) 12,830 Software 11,348 (10,211) 1,137 10,992 (10,235) 757 Trade name 3,124 (1,562) 1,562 3,635 (727) 2,908 Other 100 (100) — 100 (92) 8 Total intangible assets with finite lives 831,024 (342,296) 488,728 833,174 (311,922) 521,252 Intangible assets with indefinite lives: Trade name 23,400 — 23,400 23,400 — 23,400 Service provider network 2,000 — 2,000 2,000 — 2,000 Total intangible assets with indefinite lives 25,400 — 25,400 25,400 — 25,400 Total intangible assets $856,424 ($342,296) $514,128 $858,574 ($311,922) $546,652 At September 30, 2022, the weighted-average amortization periods remaining for developed technology, customer relationships, software, trade name and other was 12.7, 11.2, 2.3, 1.3 and 0.0 years, respectively, and the weighted-average amortization periods remaining for these finite-lived intangible assets was 12.6 years. Estimated annual amortization expense for finite-lived intangible assets subsequent to September 30, 2022 is as follows: (in thousands) Amount 2022 (remaining) $10,584 2023 42,322 2024 40,907 2025 40,587 2026 40,292 Thereafter 314,036 Total $488,728

Other Assets

Other Assets	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Other Assets The Company’s other assets at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Right-of-use asset $6,780 $6,258 Long-term sales-type lease receivable 2,558 2,860 Other long-term receivable 1,964 2,288 Total other assets $11,302 $11,406 Other long-term receivable of $0.8 million was deemed uncollectible and was written off to other expense during the year ended December 31, 2021.

Accrued and Other Current Liabi

Accrued and Other Current Liabilities	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Accrued and Other Current Liabilities	Accrued and Other Current Liabilities The Company’s accrued and other current liabilities at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Accrued taxes $9,753 $8,267 Accrued compensation and benefits 9,088 8,227 Bank overdraft 2,026 1,612 Lease liability 1,280 1,624 Severance 106 1,259 Accrued rebates payable 2,305 756 Deferred revenue 1,605 635 Accrued interest 92 72 Other 4,670 4,542 Total accrued and other current liabilities $30,925 $26,994

Debt

Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt The Company’s debt, net of unamortized deferred issuance costs, at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Total term loan outstanding $260,438 $262,501 Unamortized deferred issuance costs (4,956) (6,434) AgroFresh Fruit Protection loan outstanding 897 1,489 Less: Amounts due within one year 3,139 3,362 Total long-term debt due after one year $253,240 $254,194 Amended Credit Facility On July 27, 2020, the Company completed a comprehensive refinancing (the “ Refinancing ” ) by (i) entering into an Amended and Restated Credit Agreement (the “Amended Credit Agreement”) with the other loan parties party thereto, Bank of Montreal, as administrative agent and the lenders party thereto, and (ii) consummating the transactions contemplated by the Investment Agreement (as defined and described in Note 15 – Series B Convertible Preferred Stock and Stockholders’ Equity). The Amended Credit Agreement amends and restates in its entirety the Credit Agreement a subsidiary of the Company had with Bank of Montreal that was entered into on July 31, 2015. The Amended Credit Agreement provides for a $25.0 million revolving credit facility (the “Amended Revolving Loan”), which matures on June 30, 2024, and a $275.0 million term credit facility (the “Amended Term Loan” and, together with the Amended Revolving Loan, the “Amended Credit Facility”), which matures on December 31, 2024. The Amended Credit Facility includes a $5.0 million swingline commitment and a $10.0 million letter of credit sub-limit. Loans under the Amended Term Loan bear interest at a rate equal to, at the Company’s option, either the Adjusted Eurodollar Rate for the interest period in effect for such borrowing plus an Applicable Rate of 6.25% per annum, or the Alternate Base Rate plus an Applicable Rate of 5.25% per annum. Loans under the Amended Revolving Loan bear interest at a rate equal to, at the Company’s option, the Adjusted Eurodollar Rate for the interest period in effect for such borrowing plus the Applicable Rate ranging from 6.25% to 6.0% per annum, based on certain ratios. The interest rate was 7.25% for each of the three and nine months ended September 30, 2022. The Company is also required to pay a commitment fee on the unused portion of the Amended Revolving Loan at a rate ranging from 0.5% to 0.375%, based on certain ratios. The Company is required to make mandatory prepayments of outstanding indebtedness under the Amended Credit Agreement under certain circumstances. During the three months ended March 31, 2021, a prepayment of principal of $9.1 million was made. The obligations of AgroFresh Inc., a wholly-owned subsidiary of the Company and the borrower under the Amended Credit Facility, are initially guaranteed by the Company and the Company’s wholly-owned subsidiary, AF Solutions Holdings LLC (together with AgroFresh Inc. and the Company, the “Loan Parties”) and may in the future be guaranteed by certain other domestic subsidiaries of the Company. The obligations of the Loan Parties under the Amended Credit Agreement and other loan documents are secured, subject to customary permitted liens and other agreed upon exceptions, by a perfected security interest in all tangible and intangible assets of the Loan Parties, except for certain excluded assets, and equity interests of certain foreign subsidiaries of the Loan Parties held by the Loan Parties (subject to certain exclusions and limitations). The interest expense related to the amortization of the Amended Credit Facility debt issuance costs was $0.5 million during each of the three months ended September 30, 2022 and 2021 and $1.5 million and $1.7 million for the nine months ended September 30, 2022 and 2021, respectively. As of September 30, 2022, there were $5.0 million of unamortized deferred issuance costs. At September 30, 2022, there was $260.4 million outstanding under the Amended Term Loan and no balance outstanding under the Amended Revolving Loan. At September 30, 2022, the Company evaluated the amount recorded under the Amended Term Loan and determined that the fair value was approximately $255.2 million. The fair value of the debt is based on quoted inactive market prices and is therefore classified as Level 2 within the valuation hierarchy. Certain restrictive covenants are contained in the Amended Credit Agreement, and the Company was in compliance with these covenants as of September 30, 2022. AgroFresh Fruit Protection Debt On March 23, 2020, AgroFresh Fruit Protection entered into a €1.0 million loan agreement with Banco Santander, S.A., which provides funding through March 2023 at a 1.5% interest rate. In May 2020, AgroFresh Fruit Protection entered into a €0.3 million loan agreement with BBVA, which provides funding through May 2025 at a 2.2% interest rate. In July 2020, AgroFresh Fruit Protection entered into a €0.6 million loan agreement with Banco Santander, S.A., which provides funding through July 2025 at a 2.5% interest rate. Scheduled principal repayments of the Company's debt subsequent to September 30, 2022 are as follows: (in thousands) Amount 2022 (remaining) $830 2023 3,049 2024 257,212 2025 244 Total $261,335

Leases

Leases	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Leases	LeasesThe Company enters into lease agreements for certain facilities and vehicles that are primarily used in the ordinary course of business. These leases are accounted for as operating leases, whereby lease expense is recognized on a straight-line basis over the term of the lease. Most leases include an option to extend or renew the lease term. The exercise of the renewal option is at the Company's discretion. The operating lease liability includes lease payments related to options to extend or renew the lease term if the Company is reasonably certain of exercising those options. The Company, in determining the present value of lease payments, uses the Company’s incremental secured borrowing rate commensurate with the term of the underlying lease. Lease expense is primarily included in general and administrative expenses in the unaudited condensed consolidated statements of operations. Additional information regarding the Company's operating leases is as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2022 2021 2022 2021 Operating Lease Cost Operating leases $453 $546 $1,450 $1,649 Short-term leases (1) 339 318 966 732 Total lease expense $792 $864 $2,416 $2,381 (1) Leases with an initial term of twelve months or less are not recorded on the balance sheet. Other information on operating leases: Nine Months Ended September 30, 2022 2021 Cash payments included in operating cash flows $1,407 $1,689 Right-of-use assets obtained in exchange for new lease $2,885 $1,665 Weighted average discount rate 7.71 % 8.39 % Weighted average remaining lease term in years 5.9 years 5.5 years The following table presents the contractual maturities of the Company's lease liabilities as of September 30, 2022. (in thousands) Lease Liability Remainder of 2022 $470 2023 1,698 2024 1,467 2025 1,281 2026 1,180 Thereafter 2,685 Total undiscounted lease payments 8,781 Less: present value adjustment 1,714 Operating lease liability $7,067

Other Noncurrent Liabilities

Other Noncurrent Liabilities	9 Months Ended
	Sep. 30, 2022
Liabilities, Other than Long-Term Debt, Noncurrent [Abstract]
Other Noncurrent Liabilities	Other Noncurrent Liabilities The Company’s other noncurrent liabilities at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Lease liability $5,787 $4,790 Other (1) 1,274 1,466 Total other noncurrent liabilities $7,061 $6,256 (1) Other noncurrent liabilities include long-term rebates and pension liabilities.

Severance

Severance	9 Months Ended
	Sep. 30, 2022
Compensation Related Costs [Abstract]
Severance	SeveranceSeverance expense was $0.1 million and $0.0 million for the three months ended September 30, 2022 and 2021, respectively, and $0.9 million and $1.6 million for the nine months ended September 30, 2022 and 2021, respectively. These amounts, which do not include stock compensation expense, were recorded in selling, general and administrative expense in the unaudited condensed consolidated statements of operations. As of September 30, 2022 and December 31, 2021, the Company had $0.1 million and $1.3 million of severance liability, respectively.

Redeemable Non-Controlling Inte

Redeemable Non-Controlling Interest ("NCI")	9 Months Ended
	Sep. 30, 2022
Noncontrolling Interest [Abstract]
Redeemable Non-Controlling Interest ("NCI")	Redeemable Non-Controlling Interest ("NCI") On November 7, 2017, the Company entered into a definitive agreement to acquire a controlling-interest in AgroFresh Fruit Protection. The transaction was closed on December 1, 2017. At the effective date of the acquisition, the Company acquired 75% of the outstanding capital stock of AgroFresh Fruit Protection. In connection with the acquisition of AgroFresh Fruit Protection, the Company concurrently entered into option agreements ("Option Agreement") with the Seller related to the remaining 25% equity interest. The Option Agreement permits the residual interest to be "put" by the Seller to the Company, or to allow the Company to "call" the residual interest gradually over time as outlined in the agreement. The Seller's ownership of AgroFresh Fruit Protection represents a NCI to the Company, which is classified outside of stockholders' equity as the option of the Seller is redeemable. As of September 30, 2022 the carrying amount of the NCI was $6.9 million in the unaudited condensed consolidated balance sheet. Any changes in the redemption value of the NCI are included as an adjustment to Additional paid-in capital on the balance sheet. The following table summarizes the changes to the Company's redeemable NCI. (in thousands) September 30, 2022 December 31, 2021 Beginning balance ($7,787) ($8,446) Net loss attributable to redeemable non-controlling interest 910 2,258 Adjustment of NCI to redemption value — (1,599) Ending balance ($6,877) ($7,787)

Series B Convertible Preferred

Series B Convertible Preferred Stock and Stockholders' Equity	9 Months Ended
	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Series B Convertible Preferred Stock and Stockholders' Equity	Series B Convertible Preferred Stock and Stockholders’ Equity Series B Convertible Preferred Stock On June 13, 2020, the Company entered into an Investment Agreement (the “Investment Agreement”) with PSP, an affiliate of Paine Schwartz Partners, LLC, pursuant to which, subject to certain closing conditions, PSP agreed to purchase in a private placement an aggregate of $150,000,000 of convertible preferred equity of the Company. The transaction closed on July 27, 2020 (the "Closing Date"), and a total of 150,000 shares of the Company’s newly-designated Series B-1 Convertible Preferred Stock, par value $0.0001 per share (the “Series B-1 Preferred Stock”), were purchased in such transaction (the “Private Placement”). On September 22, 2020, following the approval of the transactions contemplated by the Investment Agreement by the necessary regulatory body, the Company issued to PSP, for no additional consideration, a total of 150,000 shares of the Company’s newly-designated Series B-2 Convertible Preferred Stock, par value $0.0001 per share (the “Series B-2 Preferred Stock”). On September 25, 2020 (the "Exchange Date"), PSP elected to exchange the shares of the Company’s Series B-1 Convertible Preferred Stock and Series B-2 Preferred Stock held by it for a total of 150,000 shares of the Company’s newly-designated Series B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”). Accordingly, effective as of the Exchange Date, the Company issued 150,000 shares of Series B Convertible Preferred Stock, par value $0.0001 per share, to PSP and all of the shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock held by PSP were cancelled. No shares of Series B-1 Preferred Stock or Series B-2 Preferred Stock were outstanding as of September 30, 2022. The Series B Preferred Stock ranks senior to the shares of the Company’s common stock with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. The Series B Preferred Stock has a liquidation preference of $1,000 per share (the “Stated Value”). Holders of the Series B Preferred Stock are entitled to a cumulative dividend at a rate of 16% per annum, of which 50% was payable in cash and 50% was payable in kind until the first anniversary of the Closing Date, after which 50% is payable in cash, 37.5% is payable in kind, and the remaining 12.5% is payable in cash or in kind, at the Company’s option, subject in each case to adjustment under certain circumstances. Dividends on the Series B Preferred Stock are cumulative and payable quarterly in arrears. All dividends that are paid in kind will accrete to, and increase, the Stated Value. The applicable dividend rate is subject to increase by 2% per annum during any period that the Company is in breach of certain provisions of the Certificate of Designation of the Series B Preferred Stock. The Series B Preferred Stock has been classified as temporary equity as it may be contingently redeemable in the event of a change of control, which is outside of the Company's control. Associated with the Series B Preferred Stock, the Company paid dividends of $3.3 million in kind and $3.3 million in cash during the three months ended September 30, 2022, and $9.0 million in kind and $10.6 million in cash during the nine months ended September 30, 2022. The Company paid dividends of $2.3 million in kind and $3.9 million in cash during the three months ended September 30, 2021, and $8.6 million in kind and $10.0 million in cash during the nine months ended September 30, 2021 associated with the Series B Preferred Stock. As of September 30, 2022 and December 31, 2021, the Company had no accrued dividends. The Series B Preferred Stock is convertible into Common Stock at the election of the holder at any time at an initial conversion price of $5.00 (“Conversion Price”). The Conversion Price is subject to customary adjustments, including for stock splits and other reorganizations affecting the Common Stock and pursuant to certain anti-dilution provisions for below market issuances. As of September 30, 2022 and December 31, 2021, the maximum number of shares of common stock that could be issued upon conversion of the outstanding shares of Series B Preferred Stock was 34.0 million and 32.2 million shares, respectively. During the three months ended March 31, 2021, the Company redeemed 4,954 shares of Series B Preferred Stock for $5.3 million. The below table outlines the change in Series B Preferred Stock during the nine months ended September 30, 2022 and the year ended December 31, 2021. Series B Convertible Preferred Stock (in thousands) Shares Amount Balance at December 31, 2020 150 $143,728 Redemption of shares (5) (5,330) In kind dividend — 10,988 Balance at December 31, 2021 145 149,386 In kind dividend — 9,012 Balance at September 30, 2022 145 $158,398 In connection with the consummation of the Investment Agreement, the Company and PSP entered into a Registration Rights Agreement (as amended, the “Registration Rights Agreement”), dated as of July 27, 2020. The Registration Rights Agreement provides that the Company will use its commercially reasonable efforts to prepare and file a shelf registration statement with the SEC within 30 days following a written request by PSP, and will use its commercially reasonable efforts to cause such shelf registration statement to be declared effective as promptly as is reasonably practicable after its filing to permit the public resale of registrable securities covered by the Registration Rights Agreement. The registrable securities generally include any shares of the Company’s common stock into which the Series B Preferred Stock is convertible, and any other securities issued or issuable with respect to any such shares of common stock by way of share split, share dividend, distribution, recapitalization, merger, exchange, replacement or similar event or otherwise. Common Stock The authorized common stock of the Company consists of 400 million shares with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share of common stock. As of September 30, 2022, there were approximately 53.0 million shares of common stock outstanding. Series A Preferred Stock The Company has one share of Series A Preferred Stock outstanding, which is owned by R&H. R&H, voting as a separate class, is entitled to appoint one director to the Company’s board of directors for so long as R&H beneficially holds 10% or more of the aggregate amount of the outstanding shares of common stock and non-voting common stock of the Company. The Series A Preferred Stock has no other rights.

Stock-based Compensation

Stock-based Compensation	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation The Company's stock-based compensation is in accordance with the Company's amended 2015 Incentive Compensation Plan (the “Plan”), pursuant to which the Compensation Committee of the Company is authorized to grant up to 13.7 million shares to officers and employees of the Company, in the form of equity-based awards, including time or performance based options and restricted stock. In addition, the Company may grant cash-settled awards, including stock-appreciation rights (SARs) and phantom stock awards. In June 2019, the Company's shareholders approved the 2019 Employee Stock Purchase Plan (the "ESPP"), which was effective July 1, 2019. In August 2021, the number of shares reserved for issuance under the ESPP was increased to 1.25 million. The ESPP allows eligible employees to purchase shares of common stock at a discount of up to 15% through payroll deductions of their eligible compensation, subject to any plan limitations. The ESPP provides for six-month offering periods beginning January 1 and July 1 of each year, and each offering period consists of a six-month purchase period. On each purchase date, eligible employees may purchase the Company's common stock at a price per share equal to 85% of the lesser of (1) the fair market value of the common stock on the offering date or (2) the fair market value of the common stock on the purchase date. As of September 30, 2022, 564,233 shares had been issued under the ESPP. Stock compensation expense for equity-classified and liability-classified awards was $1.1 million and $1.0 million for the three months ended September 30, 2022 and 2021, respectively. Stock compensation expense for equity-classified and liability-classified awards was $3.4 million and $2.1 million for the nine months ended September 30, 2022 and 2021, respectively. Stock compensation expense is recognized in cost of goods sold, selling, general and administrative expenses and research and development expenses. At September 30, 2022, there was $7.4 million of unrecognized compensation cost relating to outstanding unvested equity instruments expected to be recognized over the weighted average period of 1.8 years.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. The Company had a net loss for the three months ended September 30, 2022 and 2021. Therefore, the effect of stock-based awards including options, restricted stock and restricted stock units outstanding at September 30, 2022 and 2021 were excluded in the computation of diluted loss per share because their inclusion would have been anti-dilutive. The following table is a reconciliation of the weighted-average common shares outstanding used for the computation of basic and diluted net loss per share: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2022 2021 2022 2021 Basic weighted-average number of shares of common stock outstanding 52,400 51,583 52,077 51,323 Effect of dilutive options, restricted stock and restricted stock units — — — — Diluted weighted-average number of shares of common stock outstanding 52,400 51,583 52,077 51,323 The following represents the weighted average number of shares that could potentially dilute basic earnings per share in the future: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2022 2021 2022 2021 Convertible preferred stock 33,324 31,242 32,731 30,955 Stock-based compensation awards (1) : Stock options 1,555 1,446 1,526 1,114 Restricted stock awards and restricted stock units 5,165 3,790 4,633 3,214 (1) SARs and phantom stock awards are payable in cash and will therefore have no impact on number of shares.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe provision for income taxes consists of provisions for federal, state and foreign income taxes. The effective tax rates for the periods ended September 30, 2022 and September 30, 2021, reflect the Company’s expected tax rate on reported income (loss) from continuing operations before income tax and tax adjustments. The Company operates in a global environment with significant operations in the U.S. and various other jurisdictions outside the U.S. Accordingly, the consolidated income tax rate is a composite rate reflecting the Company’s earnings and the applicable tax rates in the various jurisdictions where the Company operates. The Company's U.S. operations have incurred cumulative taxable losses through September 30, 2022. The Company’s U.S. net operating loss carry forwards and carry forwards of other tax attributes are subject to review and possible adjustment by the Internal Revenue Service and state tax authorities. The utilization of the tax attributes have become restricted because of certain cumulative changes in the ownership interest of significant shareholders over a three-year period in excess of 50%, as defined under Section 382 and Section 383 of the Internal Revenue Code of 1986, as amended, as well as similar state tax provisions. This limits the amount of the tax attributes that the Company can utilize annually to offset future taxable income or tax liabilities. The amount of the annual limitation, if any, was determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. Please refer to Note 3 - Related Party Transactions regarding the ownership change in the quarter ended September 30, 2020. The Company completed a Section 382 study and determined the ownership change gave rise to the restrictions that will limit the realizability of certain U.S. tax attributes and built-in losses related to future intangible amortization tax deductions. These limitations apply to the corresponding tax attributes and built-in losses incurred before the ownership change. The effective tax rate for the nine months ended September 30, 2022 differs from the U.S. statutory tax rate of 21%, primarily because of changes in valuation allowance positions related to certain foreign jurisdictions, taxable foreign inclusions within the U.S., and certain non-deductible items. The Company's effective tax rate for the three and nine months ended September 30, 2022 was (13.1)% and 9.3%, compared to the effective tax rate for the three and nine months ended September 30, 2021 of 20.4% and (35.6)%.

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Information	Segment InformationASC 280 requires use of the management approach for segment reporting. The management approach is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. Through the nine months ended September 30, 2021, the Company had operated and managed our business as two reportable segments, AgroFresh Core and AgroFresh Fruit Protection (formerly Tecnidex). Due to changes in senior management, as well as the integration of AgroFresh Fruit Protection with the Company's Core business operational and reporting structure, during the fourth quarter of 2021, the Company determined that it has one reportable segment as of December 31, 2021. Since the Company operates in one operating segment, all required financial segment information can be found in the unaudited condensed consolidated financial statements.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company is currently involved in various claims and legal actions that arise in the ordinary course of business. The Company has recorded reserves for loss contingencies based on the specific circumstances of each case. Such reserves are recorded when it is probable that a loss has been incurred as of the balance sheet date and can be reasonably estimated. Although the results of litigation and claims can never be predicted with certainty, the Company does not believe that the ultimate resolution of these actions will have a material adverse effect on the Company’s business, financial condition or results of operations. On October 14, 2019, the Company was awarded a verdict of $31.1 million in damages, related to, among other things, trade secret misappropriation and willful patent infringement, in its litigation against Decco Post-Harvest, Inc. ("Decco") and Decco's parent company, UPL Limited. The award was subsequently reduced by $18 million in connection with post-verdict review by the Court. During the three months ended March 31, 2021, the lawsuit was settled, paid and is considered closed. Purchase Commitments The Company has various purchasing contracts for contract manufacturing and research and development services which are based on the requirements of the business. Generally, the contracts are at prices not in excess of current market price and do not commit the business to obligations outside the normal customary terms for similar contracts, and these payment obligations are considered insignificant.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Liabilities Measured at Fair Value on a Recurring Basis The following table presents the fair value of the Company's financial instruments that are measured at fair value on a recurring basis as of September 30, 2022. (in thousands) Level 3 Liability-classified stock compensation (1) $168 The following table presents the fair value of the Company's financial instruments that are measured at fair value on a recurring basis as of December 31, 2021. (in thousands) Level 3 Liability-classified stock compensation (1) $241 (1) The fair values of market-based phantom shares granted in 2020 were estimated using a Monte Carlo simulation pricing model with the assumptions described below: Grant date fair value $1.70 Risk-free interest rate 0.27% Expected life (years) 2.71 Estimated volatility factor 65.8% Expected dividends None There were no transfers between Level 1 and Level 2 and no transfers out of Level 3 of the fair value hierarchy during the nine months ended September 30, 2022. At September 30, 2022, the Company evaluated the amount recorded under the Amended Term Loan and determined that the fair value was approximately $255.2 million. The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value. Changes in Financial Instruments Measured at Level 3 Fair Value on a Recurring Basis The following table presents the changes during the periods presented in our Level 3 financial instruments that are measured at fair value on a recurring basis. (in thousands) Liability-classified stock compensation Balance, December 31, 2021 $241 Stock compensation activity (73) Balance, September 30, 2022 $168

Other Income (Expense)

Other Income (Expense)	9 Months Ended
	Sep. 30, 2022
Other Income and Expenses [Abstract]
Other Income (Expense)	Other Income (Expense)The Company had other income of $0.0 million and other expense of $0.3 million for the three months ended September 30, 2022 and September 30, 2021, respectively. During the nine months ended September 30, 2022, the Company had other income of $0.5 million related to the receipt of data sharing income. During the nine months ended September 30, 2021 the Company had other income of $14.1 million due to the receipt of proceeds from the settlement of a litigation matter.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn October 24, 2022, a special committee of the Company’s board of directors agreed with Paine Schwartz Partners, LLC (“Paine Schwartz”) to pursue a transaction in which Paine Schwartz would acquire all of the outstanding common stock of the Company, which transaction would be conditioned upon, among other things, approval of the holders of a majority of the Common Stock owned by disinterested stockholders. This proposed transaction is not yet certain and is subject to, among other things, Paine Schwartz's satisfaction of confirmatory diligence and negotiation and execution of definitive documentation. The potential timing of this proposed transaction, if effected, is not yet known, and no agreement between Paine Schwartz and the Company relating to the proposed transaction will be created unless definitive documentation is executed and delivered by the appropriate parties.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policy)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. For additional information, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2021. Certain prior period amounts have been reclassified to conform to the current year presentation.
Adoption of Highly Inflationary Accounting in Argentina and Turkey	Adoption of Highly Inflationary Accounting in Argentina and Turkey GAAP requires the use of highly inflationary accounting for countries whose cumulative three-year inflation rate exceeds 100 percent. The Company closely monitors the inflation data and currency volatility where there are multiple data sources for measuring and reporting inflation in applicable countries. In the second quarter of 2018, the Argentine peso rapidly devalued relative to the U.S. dollar, which along with increased inflation, indicated that the three-year cumulative inflation rate in that country exceeded 100 percent as of June 30, 2018. As a result, the Company elected to adopt highly inflationary accounting as of July 1, 2018 for its subsidiary in Argentina. As the three-year cumulative inflation rate exceeded 100 percent as of September 30, 2022, there is no change to highly inflationary accounting in Argentina. In the first half of 2022, the Turkish lira rapidly devalued relative to the U.S. dollar, which along with increased inflation, indicated that the three-year cumulative inflation rate in that country exceeded 100 percent as of April 1, 2022. As a result, the Company elected to adopt highly inflationary accounting as of April 1, 2022 for its subsidiary in Turkey.
Disaggregation of Revenue and Contract Assets and Liabilities	Disaggregation of Revenue The Company disaggregates revenue from contracts with customers into geographic region, product and timing of transfer of goods and services. The Company determined that disaggregating revenue into these categories achieves the disclosure objective of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues for the three months ended September 30, 2022 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $14,592 $24,344 $861 $1,963 $41,760 Fungicides, disinfectants and coatings 371 2,603 669 — 3,643 Other* 193 1,392 743 33 2,361 $15,156 $28,339 $2,273 $1,996 $47,764 Pattern of Revenue Recognition Products transferred at a point in time $15,033 $28,196 $2,089 $1,933 $47,251 Services transferred over time 123 143 184 63 513 $15,156 $28,339 $2,273 $1,996 $47,764 Revenues for the three months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,677 $23,286 $781 $1,569 $43,313 Fungicides, disinfectants and coatings 917 3,182 1,283 — 5,382 Other* 127 129 180 47 483 $18,721 $26,597 $2,244 $1,616 $49,178 Pattern of Revenue Recognition Products transferred at a point in time $18,603 $26,468 $2,064 $1,583 $48,718 Services transferred over time 118 129 180 33 460 $18,721 $26,597 $2,244 $1,616 $49,178 Revenues for the nine months ended September 30, 2022 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,727 $36,149 $23,901 $13,885 $91,662 Fungicides, disinfectants and coatings 371 12,961 4,493 93 17,918 Other* 509 1,790 1,226 300 3,825 $18,607 $50,900 $29,620 $14,278 $113,405 Pattern of Revenue Recognition Products transferred at a point in time $18,231 $50,217 $29,093 $14,094 $111,635 Services transferred over time 376 683 527 184 1,770 $18,607 $50,900 $29,620 $14,278 $113,405 Revenues for the nine months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $20,020 $34,083 $25,145 $12,745 $91,993 Fungicides, disinfectants and coatings 931 11,044 3,829 — 15,804 Other* 519 602 981 195 2,297 $21,470 $45,729 $29,955 $12,940 $110,094 Pattern of Revenue Recognition Products transferred at a point in time $20,958 $45,131 $29,416 $12,774 $108,279 Services transferred over time 512 598 539 166 1,815 $21,470 $45,729 $29,955 $12,940 $110,094 *Other includes FreshCloud, technical services and sales-type equipment leases related to AgroFresh Fruit Protection. (1) North America includes the United States and Canada. (2) EMEA includes Europe, the Middle East and Africa. (3) Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru and Uruguay. (4) Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan and Thailand. Contract Assets and Liabilities Accounting Standards Codification ("ASC") 606 Revenue from contracts with Customers requires an entity to present a revenue contract as a contract asset when the entity performs its obligations under the contract by transferring goods or services to a customer before the customer pays consideration or before payment is due. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g., receivable), before the entity transfers a good or service to the customer. The following table presents changes in the Company’s contract assets and liabilities during the nine months ended September 30, 2022 and the year ended December 31, 2021: (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $795 12,609 (10,342) $3,062 Contract liabilities: Deferred revenue $635 4,658 (3,688) 1,605 (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $1,484 17,617 (18,306) $795 Contract liabilities: Deferred revenue $1,474 4,123 (4,962) $635
Recently Issued Accounting Standards and Pronouncements	Recently Issued Accounting Standards and Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . The amendments simplify the accounting for income taxes by removing certain exceptions to the general principles of Topic 740, "Income Taxes" and also improve consistent application by clarifying and amending existing guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted the new guidance on January 1, 2021. The adoption of the new guidance did not have a material impact on the condensed consolidated financial statements of the Company. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The amendments provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments are intended to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. The new standard is effective on a date selected by the Company between March 12, 2020 and December 31, 2022. The Company is currently evaluating the impact of adopting this guidance.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule of disaggregated revenue	The Company determined that disaggregating revenue into these categories achieves the disclosure objective of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues for the three months ended September 30, 2022 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $14,592 $24,344 $861 $1,963 $41,760 Fungicides, disinfectants and coatings 371 2,603 669 — 3,643 Other* 193 1,392 743 33 2,361 $15,156 $28,339 $2,273 $1,996 $47,764 Pattern of Revenue Recognition Products transferred at a point in time $15,033 $28,196 $2,089 $1,933 $47,251 Services transferred over time 123 143 184 63 513 $15,156 $28,339 $2,273 $1,996 $47,764 Revenues for the three months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,677 $23,286 $781 $1,569 $43,313 Fungicides, disinfectants and coatings 917 3,182 1,283 — 5,382 Other* 127 129 180 47 483 $18,721 $26,597 $2,244 $1,616 $49,178 Pattern of Revenue Recognition Products transferred at a point in time $18,603 $26,468 $2,064 $1,583 $48,718 Services transferred over time 118 129 180 33 460 $18,721 $26,597 $2,244 $1,616 $49,178 Revenues for the nine months ended September 30, 2022 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $17,727 $36,149 $23,901 $13,885 $91,662 Fungicides, disinfectants and coatings 371 12,961 4,493 93 17,918 Other* 509 1,790 1,226 300 3,825 $18,607 $50,900 $29,620 $14,278 $113,405 Pattern of Revenue Recognition Products transferred at a point in time $18,231 $50,217 $29,093 $14,094 $111,635 Services transferred over time 376 683 527 184 1,770 $18,607 $50,900 $29,620 $14,278 $113,405 Revenues for the nine months ended September 30, 2021 (in thousands) Region North America EMEA Latin America Asia Pacific Total Revenues Product 1-MCP based $20,020 $34,083 $25,145 $12,745 $91,993 Fungicides, disinfectants and coatings 931 11,044 3,829 — 15,804 Other* 519 602 981 195 2,297 $21,470 $45,729 $29,955 $12,940 $110,094 Pattern of Revenue Recognition Products transferred at a point in time $20,958 $45,131 $29,416 $12,774 $108,279 Services transferred over time 512 598 539 166 1,815 $21,470 $45,729 $29,955 $12,940 $110,094 *Other includes FreshCloud, technical services and sales-type equipment leases related to AgroFresh Fruit Protection. (1) North America includes the United States and Canada. (2) EMEA includes Europe, the Middle East and Africa. (3) Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru and Uruguay. (4) Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan and Thailand.
Schedule of changes in contract assets and liabilities	The following table presents changes in the Company’s contract assets and liabilities during the nine months ended September 30, 2022 and the year ended December 31, 2021: (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $795 12,609 (10,342) $3,062 Contract liabilities: Deferred revenue $635 4,658 (3,688) 1,605 (in thousands) Balance at Additions Deductions Balance at Contract assets: Unbilled revenue $1,484 17,617 (18,306) $795 Contract liabilities: Deferred revenue $1,474 4,123 (4,962) $635

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Schedule of inventories	Inventories at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Raw material $3,609 $2,726 Work-in-process 4,071 3,746 Finished goods 16,187 12,520 Supplies 890 788 Total inventories $24,757 $19,780

Other Current Assets (Tables)

Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of other current assets	The Company's other current assets at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 VAT receivable $11,547 $10,220 Prepaid income tax asset 7,991 6,256 Prepaid and other current assets 3,655 3,402 Total other current assets $23,193 $19,878

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Property and equipment at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands, except for useful life data) Useful life September 30, 2022 December 31, 2021 Buildings and leasehold improvements 7-20 $6,766 $6,967 Machinery & equipment 1-12 14,434 13,158 Furniture 1-12 2,797 2,927 Construction in progress 1,230 1,780 25,227 24,832 Less: accumulated depreciation (14,259) (12,846) Total property and equipment, net $10,968 $11,986

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of changes in the carrying amount of goodwill	Changes in the carrying amount of goodwill for the year ended December 31, 2021 were as follows: (in thousands) December 31, 2021 Beginning balance $6,925 Foreign currency translation (545) Impairment of goodwill (6,380) Ending balance $—
Schedule of other intangible assets	The Company’s intangible assets at September 30, 2022 and December 31, 2021 consisted of the following: September 30, 2022 December 31, 2021 (in thousands) Gross Carrying Accumulated Net Gross Carrying Accumulated Net Intangible assets with finite lives: Developed technology $798,330 ($323,142) $475,188 $798,669 ($293,920) $504,749 Customer relationships 18,122 (7,281) 10,841 19,778 (6,948) 12,830 Software 11,348 (10,211) 1,137 10,992 (10,235) 757 Trade name 3,124 (1,562) 1,562 3,635 (727) 2,908 Other 100 (100) — 100 (92) 8 Total intangible assets with finite lives 831,024 (342,296) 488,728 833,174 (311,922) 521,252 Intangible assets with indefinite lives: Trade name 23,400 — 23,400 23,400 — 23,400 Service provider network 2,000 — 2,000 2,000 — 2,000 Total intangible assets with indefinite lives 25,400 — 25,400 25,400 — 25,400 Total intangible assets $856,424 ($342,296) $514,128 $858,574 ($311,922) $546,652
Schedule of estimated annual amortization expense for finite-lived intangible assets	Estimated annual amortization expense for finite-lived intangible assets subsequent to September 30, 2022 is as follows: (in thousands) Amount 2022 (remaining) $10,584 2023 42,322 2024 40,907 2025 40,587 2026 40,292 Thereafter 314,036 Total $488,728

Other Assets (Tables)

Other Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of other assets	The Company’s other assets at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Right-of-use asset $6,780 $6,258 Long-term sales-type lease receivable 2,558 2,860 Other long-term receivable 1,964 2,288 Total other assets $11,302 $11,406

Accrued and Other Current Lia_2

Accrued and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Accrued and other current liabilities	The Company’s accrued and other current liabilities at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Accrued taxes $9,753 $8,267 Accrued compensation and benefits 9,088 8,227 Bank overdraft 2,026 1,612 Lease liability 1,280 1,624 Severance 106 1,259 Accrued rebates payable 2,305 756 Deferred revenue 1,605 635 Accrued interest 92 72 Other 4,670 4,542 Total accrued and other current liabilities $30,925 $26,994

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of debt, net of unamortized discount and deferred financing fees	The Company’s debt, net of unamortized deferred issuance costs, at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Total term loan outstanding $260,438 $262,501 Unamortized deferred issuance costs (4,956) (6,434) AgroFresh Fruit Protection loan outstanding 897 1,489 Less: Amounts due within one year 3,139 3,362 Total long-term debt due after one year $253,240 $254,194
Schedule of principal repayments under the term loan	Scheduled principal repayments of the Company's debt subsequent to September 30, 2022 are as follows: (in thousands) Amount 2022 (remaining) $830 2023 3,049 2024 257,212 2025 244 Total $261,335

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Schedule of additional information of operating leases	Additional information regarding the Company's operating leases is as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2022 2021 2022 2021 Operating Lease Cost Operating leases $453 $546 $1,450 $1,649 Short-term leases (1) 339 318 966 732 Total lease expense $792 $864 $2,416 $2,381 (1) Leases with an initial term of twelve months or less are not recorded on the balance sheet. Other information on operating leases: Nine Months Ended September 30, 2022 2021 Cash payments included in operating cash flows $1,407 $1,689 Right-of-use assets obtained in exchange for new lease $2,885 $1,665 Weighted average discount rate 7.71 % 8.39 % Weighted average remaining lease term in years 5.9 years 5.5 years
Schedule of maturities of lease liabilities	The following table presents the contractual maturities of the Company's lease liabilities as of September 30, 2022. (in thousands) Lease Liability Remainder of 2022 $470 2023 1,698 2024 1,467 2025 1,281 2026 1,180 Thereafter 2,685 Total undiscounted lease payments 8,781 Less: present value adjustment 1,714 Operating lease liability $7,067

Other Noncurrent Liabilities (T

Other Noncurrent Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Liabilities, Other than Long-Term Debt, Noncurrent [Abstract]
Other noncurrent liabilities	The Company’s other noncurrent liabilities at September 30, 2022 and December 31, 2021 consisted of the following: (in thousands) September 30, 2022 December 31, 2021 Lease liability $5,787 $4,790 Other (1) 1,274 1,466 Total other noncurrent liabilities $7,061 $6,256 (1) Other noncurrent liabilities include long-term rebates and pension liabilities.

Redeemable Non-Controlling In_2

Redeemable Non-Controlling Interest ("NCI") (Tables)	9 Months Ended
	Sep. 30, 2022
Noncontrolling Interest [Abstract]
Temporary equity	The following table summarizes the changes to the Company's redeemable NCI. (in thousands) September 30, 2022 December 31, 2021 Beginning balance ($7,787) ($8,446) Net loss attributable to redeemable non-controlling interest 910 2,258 Adjustment of NCI to redemption value — (1,599) Ending balance ($6,877) ($7,787) Series B Convertible Preferred Stock (in thousands) Shares Amount Balance at December 31, 2020 150 $143,728 Redemption of shares (5) (5,330) In kind dividend — 10,988 Balance at December 31, 2021 145 149,386 In kind dividend — 9,012 Balance at September 30, 2022 145 $158,398

Series B Convertible Preferre_2

Series B Convertible Preferred Stock and Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Change in Series B Preferred Stock	The following table summarizes the changes to the Company's redeemable NCI. (in thousands) September 30, 2022 December 31, 2021 Beginning balance ($7,787) ($8,446) Net loss attributable to redeemable non-controlling interest 910 2,258 Adjustment of NCI to redemption value — (1,599) Ending balance ($6,877) ($7,787) Series B Convertible Preferred Stock (in thousands) Shares Amount Balance at December 31, 2020 150 $143,728 Redemption of shares (5) (5,330) In kind dividend — 10,988 Balance at December 31, 2021 145 149,386 In kind dividend — 9,012 Balance at September 30, 2022 145 $158,398

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of basic and diluted earnings per share	The following table is a reconciliation of the weighted-average common shares outstanding used for the computation of basic and diluted net loss per share: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2022 2021 2022 2021 Basic weighted-average number of shares of common stock outstanding 52,400 51,583 52,077 51,323 Effect of dilutive options, restricted stock and restricted stock units — — — — Diluted weighted-average number of shares of common stock outstanding 52,400 51,583 52,077 51,323
Amounts that could potentially dilute basic earnings per share	The following represents the weighted average number of shares that could potentially dilute basic earnings per share in the future: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2022 2021 2022 2021 Convertible preferred stock 33,324 31,242 32,731 30,955 Stock-based compensation awards (1) : Stock options 1,555 1,446 1,526 1,114 Restricted stock awards and restricted stock units 5,165 3,790 4,633 3,214 (1) SARs and phantom stock awards are payable in cash and will therefore have no impact on number of shares.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Tabular disclosure of financial instruments measured at fair value on a recurring basis	The following table presents the fair value of the Company's financial instruments that are measured at fair value on a recurring basis as of September 30, 2022. (in thousands) Level 3 Liability-classified stock compensation (1) $168 The following table presents the fair value of the Company's financial instruments that are measured at fair value on a recurring basis as of December 31, 2021. (in thousands) Level 3 Liability-classified stock compensation (1) $241 (1) The fair values of market-based phantom shares granted in 2020 were estimated using a Monte Carlo simulation pricing model with the assumptions described below: Grant date fair value $1.70 Risk-free interest rate 0.27% Expected life (years) 2.71 Estimated volatility factor 65.8% Expected dividends None
Changes in financial instruments measured at level 3 fair value on a recurring basis	The following table presents the changes during the periods presented in our Level 3 financial instruments that are measured at fair value on a recurring basis. (in thousands) Liability-classified stock compensation Balance, December 31, 2021 $241 Stock compensation activity (73) Balance, September 30, 2022 $168

Description of Business (Detail

Description of Business (Details) storageRoom in Thousands	9 Months Ended
	Sep. 30, 2022 storageRoom country
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating countries (over) | country	50
Number of storage rooms (over) | storageRoom	25

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Concentration Risk [Line Items]
Unbilled revenue deductions	$ 10,342		$ 18,306
Deferred revenue deductions	$ 3,688		$ 4,962
Argentina | Geographic concentration risk | Revenue from contract with customer
Concentration Risk [Line Items]
Concentration risk percentage (as a percent)	5%	5%
Turkey | Geographic concentration risk | Revenue from contract with customer
Concentration Risk [Line Items]
Concentration risk percentage (as a percent)	2%
Subsidiaries | Argentina
Concentration Risk [Line Items]
Net assets	$ (11,300)
Subsidiaries | Turkey
Concentration Risk [Line Items]
Net assets	$ 11,000

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total Revenues	$ 47,764	$ 49,178	$ 113,405	$ 110,094
North America
Disaggregation of Revenue [Line Items]
Total Revenues	15,156	18,721	18,607	21,470
EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	28,339	26,597	50,900	45,729
Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	2,273	2,244	29,620	29,955
Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	1,996	1,616	14,278	12,940
Products transferred at a point in time
Disaggregation of Revenue [Line Items]
Total Revenues	47,251	48,718	111,635	108,279
Products transferred at a point in time | North America
Disaggregation of Revenue [Line Items]
Total Revenues	15,033	18,603	18,231	20,958
Products transferred at a point in time | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	28,196	26,468	50,217	45,131
Products transferred at a point in time | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	2,089	2,064	29,093	29,416
Products transferred at a point in time | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	1,933	1,583	14,094	12,774
Services transferred over time
Disaggregation of Revenue [Line Items]
Total Revenues	513	460	1,770	1,815
Services transferred over time | North America
Disaggregation of Revenue [Line Items]
Total Revenues	123	118	376	512
Services transferred over time | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	143	129	683	598
Services transferred over time | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	184	180	527	539
Services transferred over time | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	63	33	184	166
1-MCP based
Disaggregation of Revenue [Line Items]
Total Revenues	41,760	43,313	91,662	91,993
1-MCP based | North America
Disaggregation of Revenue [Line Items]
Total Revenues	14,592	17,677	17,727	20,020
1-MCP based | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	24,344	23,286	36,149	34,083
1-MCP based | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	861	781	23,901	25,145
1-MCP based | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	1,963	1,569	13,885	12,745
Fungicides, disinfectants and coatings
Disaggregation of Revenue [Line Items]
Total Revenues	3,643	5,382	17,918	15,804
Fungicides, disinfectants and coatings | North America
Disaggregation of Revenue [Line Items]
Total Revenues	371	917	371	931
Fungicides, disinfectants and coatings | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	2,603	3,182	12,961	11,044
Fungicides, disinfectants and coatings | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	669	1,283	4,493	3,829
Fungicides, disinfectants and coatings | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	0	0	93	0
Other
Disaggregation of Revenue [Line Items]
Total Revenues	2,361	483	3,825	2,297
Other | North America
Disaggregation of Revenue [Line Items]
Total Revenues	193	127	509	519
Other | EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	1,392	129	1,790	602
Other | Latin America
Disaggregation of Revenue [Line Items]
Total Revenues	743	180	1,226	981
Other | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	$ 33	$ 47	$ 300	$ 195

Basis of Presentation and Sum_6

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Contract assets:
Beginning balance	$ 795	$ 1,484
Additions	12,609	17,617
Deductions	(10,342)	(18,306)
Ending balance	3,062	795
Contract liabilities:
Beginning balance	635	1,474
Additions	4,658	4,123
Deductions	(3,688)	(4,962)
Ending balance	$ 1,605	$ 635

Related Party Transactions (Det

Related Party Transactions (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)	Jun. 13, 2020 board_member
Related party transactions
Board member | board_member		1
Other affiliates | Investment agreement
Related party transactions
Percent of board required for right to designate directors (as a percent)		50%
Percent ownership interest required to designate directors (as a percent)		20%
Director | Mutal services agreement
Related party transactions
Expenses paid per service agreement | $	$ 0

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw material	$ 3,609	$ 2,726
Work-in-process	4,071	3,746
Finished goods	16,187	12,520
Supplies	890	788
Total inventories	$ 24,757	$ 19,780

Other Current Assets (Details)

Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
VAT receivable	$ 11,547	$ 10,220
Prepaid income tax asset	7,991	6,256
Prepaid and other current assets	3,655	3,402
Total other current assets	$ 23,193	$ 19,878

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 25,227		$ 25,227		$ 24,832
Less: accumulated depreciation	(14,259)		(14,259)		(12,846)
Total property and equipment, net	10,968		10,968		11,986
Depreciation expense	800	$ 700	2,200	$ 2,000
Buildings and leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,766		$ 6,766		6,967
Buildings and leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)			7 years
Buildings and leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)			20 years
Machinery & equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	14,434		$ 14,434		13,158
Machinery & equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)			1 year
Machinery & equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)			12 years
Furniture
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,797		$ 2,797		2,927
Furniture | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)			1 year
Furniture | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)			12 years
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,230		$ 1,230		$ 1,780

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 6,925
Foreign currency translation	(545)
Impairment of goodwill	(6,380)
Ending balance	$ 0

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) segment	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) segment reporting_unit
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Number of operating segments | segment			1		1
Number of reporting units | reporting_unit					1
Impairment of goodwill					$ 6,380
Amortization expense	$ 10,606	$ 10,830	$ 32,032	$ 32,092
Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			12 years 7 months 6 days
Developed technology | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			12 years 8 months 12 days
Customer relationships | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			11 years 2 months 12 days
Software | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			2 years 3 months 18 days
Trade name | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			1 year 3 months 18 days
Other | Weighted average
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]
Useful life (in years)			0 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Other intangible assets:
Gross carrying amount, finite-lived	$ 831,024	$ 833,174
Gross carrying amount, indefinite-lived	25,400	25,400
Intangible Assets, Gross (Excluding Goodwill), Total	856,424	858,574
Accumulated Amortization	(342,296)	(311,922)
Total	488,728	521,252
Indefinite-Lived Intangible Assets, Net (Excluding Goodwill)	25,400	25,400
Intangible Assets, Net (Excluding Goodwill), Total	514,128	546,652
Trade name
Other intangible assets:
Gross carrying amount, indefinite-lived	23,400	23,400
Indefinite-Lived Intangible Assets, Net (Excluding Goodwill)	23,400	23,400
Service provider network
Other intangible assets:
Gross carrying amount, indefinite-lived	2,000	2,000
Indefinite-Lived Intangible Assets, Net (Excluding Goodwill)	2,000	2,000
Developed technology
Other intangible assets:
Gross carrying amount, finite-lived	798,330	798,669
Accumulated Amortization	(323,142)	(293,920)
Total	475,188	504,749
Customer relationships
Other intangible assets:
Gross carrying amount, finite-lived	18,122	19,778
Accumulated Amortization	(7,281)	(6,948)
Total	10,841	12,830
Software
Other intangible assets:
Gross carrying amount, finite-lived	11,348	10,992
Accumulated Amortization	(10,211)	(10,235)
Total	1,137	757
Trade name
Other intangible assets:
Gross carrying amount, finite-lived	3,124	3,635
Accumulated Amortization	(1,562)	(727)
Total	1,562	2,908
Other
Other intangible assets:
Gross carrying amount, finite-lived	100	100
Accumulated Amortization	(100)	(92)
Total	$ 0	$ 8

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Future Amortization (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Estimated annual amortization expense
2022 (remaining)	$ 10,584
2023	42,322
2024	40,907
2025	40,587
2026	40,292
Thereafter	314,036
Total	$ 488,728	$ 521,252

Other Assets (Details)

Other Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Sep. 30, 2022
Other Assets [Abstract]
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Total other assets	Total other assets
Right-of-use asset	$ 6,258	$ 6,780
Long-term sales-type lease receivable	2,860	2,558
Other long-term receivable	2,288	1,964
Total other assets	11,406	$ 11,302
Other long-term receivable deemed uncollectible, write off	$ 800

Accrued and Other Current Lia_3

Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Accrued taxes	$ 9,753	$ 8,267
Accrued compensation and benefits	9,088	8,227
Bank overdraft	2,026	1,612
Lease liability	1,280	1,624
Severance	106	1,259
Accrued rebates payable	2,305	756
Deferred revenue	1,605	635
Accrued interest	92	72
Other	4,670	4,542
Total accrued and other current liabilities	$ 30,925	$ 26,994
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Total accrued and other current liabilities	Total accrued and other current liabilities

Debt - Net of Unamortized Disco

Debt - Net of Unamortized Discounts and Deferred Financing Fees (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Less: Amounts due within one year	$ 3,139	$ 3,362
Total long-term debt due after one year	253,240	254,194
AgroFresh Fruit Protection loan outstanding
Debt Instrument [Line Items]
Total term loan outstanding	897	1,489
Term loan
Debt Instrument [Line Items]
Total term loan outstanding	260,438	262,501
Unamortized deferred issuance costs	$ (4,956)	$ (6,434)

Debt - Narrative (Details)

Debt - Narrative (Details) € in Millions		3 Months Ended			9 Months Ended
	Jul. 27, 2020 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Jul. 31, 2020 EUR (€)	May 31, 2020 EUR (€)	Mar. 23, 2020 EUR (€)
Credit facility
Interest rate (as a percent)		7.25%			7.25%
Amortization of deferred financing costs					$ 1,576,000	$ 1,772,000
Long term debt, gross		$ 261,335,000			261,335,000
Maximum
Credit facility
Commitment fee percentage (as a percent)	0.50%
Minimum
Credit facility
Commitment fee percentage (as a percent)	0.375%
Eurodollar
Credit facility
Margin of interest (as a percent)	6.25%
Eurodollar | Maximum
Credit facility
Margin of interest (as a percent)	6.25%
Eurodollar | Minimum
Credit facility
Margin of interest (as a percent)	6%
Base rate
Credit facility
Margin of interest (as a percent)	5.25%
Revolving loan
Credit facility
Maximum borrowing available	$ 25,000,000
Long term debt, gross		0			0
Term loan
Credit facility
Face amount	275,000,000	260,400,000			260,400,000			€ 0.6	€ 0.3	€ 1
Interest rate (as a percent)								2.50%	2.20%	1.50%
Prepayment of principal				$ 9,100,000
Deferred issuance costs, net		4,956,000			4,956,000		$ 6,434,000
Fair value of debt		255,200,000			255,200,000
Term loan | Amended Credit Facility
Credit facility
Amortization of deferred financing costs		$ 500,000	$ 500,000		$ 1,500,000	$ 1,700,000
Bridge loan
Credit facility
Maximum borrowing available	5,000,000
Letter-of-credit sub-facility
Credit facility
Maximum borrowing available	$ 10,000,000

Debt - Principal Repayments (De

Debt - Principal Repayments (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Schedule of principal repayments under the Term Loan
2022 (remaining)	$ 830
2023	3,049
2024	257,212
2025	244
Total	$ 261,335

Leases - Additional Information

Leases - Additional Information on Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Lease, Cost [Abstract]
Operating leases	$ 453	$ 546	$ 1,450	$ 1,649
Short-term leases	339	318	966	732
Total lease expense	$ 792	$ 864	2,416	2,381
Cash payments included in operating cash flows			1,407	1,689
Right-of-use assets obtained in exchange for new lease			$ 2,885	$ 1,665
Weighted average discount rate	7.71%	8.39%	7.71%	8.39%
Weighted average remaining lease term in years	5 years 10 months 24 days	5 years 6 months	5 years 10 months 24 days	5 years 6 months

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities: Current Period (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Leases [Abstract]
Remainder of 2022	$ 470
2023	1,698
2024	1,467
2025	1,281
2026	1,180
Thereafter	2,685
Total undiscounted lease payments	8,781
Less: present value adjustment	1,714
Operating lease liability	$ 7,067

Other Noncurrent Liabilities (D

Other Noncurrent Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Liabilities, Other than Long-Term Debt, Noncurrent [Abstract]
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Total other noncurrent liabilities	Total other noncurrent liabilities
Lease liability	$ 5,787	$ 4,790
Other	1,274	1,466
Total other noncurrent liabilities	$ 7,061	$ 6,256

Severance (Details)

Severance (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Compensation Related Costs [Abstract]
Severance expense	$ 0.1	$ 0	$ 0.9	$ 1.6
Severance liability	$ 0.1		$ 0.1		$ 1.3

Redeemable Non-Controlling In_3

Redeemable Non-Controlling Interest ("NCI") - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 01, 2017
Noncontrolling Interest [Line Items]
Redeemable noncontrolling interest	$ 6,877	$ 7,787	$ 8,446
Tecnidex Fruit Protection, S.A.U. | Option agreement
Noncontrolling Interest [Line Items]
Ownership percentage by noncontrolling owners (as a percent)				25%
Tecnidex Fruit Protection, S.A.U.
Noncontrolling Interest [Line Items]
Percentage of voting interests acquired (as a percent)				75%

Redeemable Non-Controlling In_4

Redeemable Non-Controlling Interest ("NCI") - Changes in Redeemable Non-controlling Interest (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance	$ (7,787)	$ (8,446)
Net loss attributable to redeemable non-controlling interest	910	2,258
Adjustment of NCI to redemption value	0	(1,599)
Ending balance	$ (6,877)	$ (7,787)

Series B Convertible Preferre_3

Series B Convertible Preferred Stock and Stockholders' Equity - Narrative (Details)			3 Months Ended			9 Months Ended		12 Months Ended
	Jun. 13, 2020 USD ($) $ / shares shares	Jul. 31, 2015 director shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($)	Mar. 31, 2021 USD ($) shares	Sep. 30, 2022 USD ($) vote $ / shares shares	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) $ / shares shares
Class of Warrant or Right [Line Items]
Preferred stock, par value (in dollars per share) | $ / shares			$ 0.0001			$ 0.0001		$ 0.0001
Preferred stock, shares outstanding (in shares)			1			1		1
Authorized common stock (in shares)			400,000,000			400,000,000		400,000,000
Par value of common stock (in dollars per share) | $ / shares			$ 0.0001			$ 0.0001		$ 0.0001
Number of votes entitled by holders of common stock for each share of common stock | vote						1
Common stock, shares outstanding (in shares)			53,044,000			53,044,000		52,418,000
Rohm and Haas
Class of Warrant or Right [Line Items]
Number of shares of Series A Preferred Stock issued as condition to consummation of business combination (in shares)		1
Number of directors preferred stockholder is entitled to appoint if minimum ownership percentage of common stock is maintained | director		1
Minimum percentage of outstanding shares of voting and non-voting common stock to be held to entitle preferred stockholder to appoint director (as a percent)		10%
Series B Convertible Stock
Class of Warrant or Right [Line Items]
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001
Accrued dividends | $			$ 0			$ 0		$ 0
Preferred stock, convertible, conversion price (in dollars per share) | $ / shares	$ 5
Redemption of shares (in shares)					4,954
Redemption of shares (in USD) | $					$ 5,300,000			$ 5,330,000
Series B Convertible Stock | Maximum
Class of Warrant or Right [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance			34,000,000			34,000,000		32,200,000
Series B Convertible Stock | Paid in-kind
Class of Warrant or Right [Line Items]
Dividends | $			$ 3,300,000	$ 2,300,000		$ 9,000,000	$ 8,600,000
Series B Convertible Stock | Cash
Class of Warrant or Right [Line Items]
Dividends | $			$ 3,300,000	$ 3,900,000		$ 10,600,000	$ 10,000,000
Series B-1 Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Preferred stock, shares outstanding (in shares)			0			0
Series B-2 Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Preferred stock, shares outstanding (in shares)			0			0
Private Placement
Class of Warrant or Right [Line Items]
Dividend rate increase (in percent)	2%
Private Placement | Dividends within first anniversary
Class of Warrant or Right [Line Items]
Percentage payable in cash	50%
Percentage payable in kind	50%
Private Placement | Dividends after first anniversary
Class of Warrant or Right [Line Items]
Percentage payable in cash	50%
Percentage payable in kind	37.50%
Percentage payable in cash or kind	12.50%
Private Placement | Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Sale of stock, consideration received on transaction | $	$ 150,000,000
Private Placement | Series B Convertible Stock
Class of Warrant or Right [Line Items]
Preferred stock issued (in shares)	150,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001
Convertible preferred stock, shares issued upon conversion (in shares)	150,000
Liquidation preference (in dollars per share) | $ / shares	$ 1,000
Cumulative dividend rate (in percent)	16%
Private Placement | Series B-1 Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Preferred stock issued (in shares)	150,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001
Liquidation preference (in dollars per share) | $ / shares	$ 1,000
Cumulative dividend rate (in percent)	16%
Private Placement | Series B-2 Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Preferred stock issued (in shares)	150,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001

Series B Convertible Preferre_4

Series B Convertible Preferred Stock and Stockholders' Equity - Temporary Equity (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2022	Dec. 31, 2021
Increase (Decrease) in Temporary Equity [Roll Forward]
Balance at beginning of period (in USD)		$ 149,386
Balance at end of period (in USD)		$ 158,398	$ 149,386
Series B Convertible Stock
Increase (Decrease) in Temporary Equity [Roll Forward]
Balance at beginning of period (in shares)	150,000	145,000	150,000
Balance at beginning of period (in USD)	$ 143,728	$ 149,386	$ 143,728
Redemption of shares			(5,000)
Redemption of shares (in USD)	$ (5,300)		$ (5,330)
In kind dividend (in shares)			0
In kind dividend (in USD)			$ 10,988
Additional in kind dividend (in shares)		0
Additional in kind dividend (in USD)		$ 9,012
Balance at end of period (in shares)		145,000	145,000
Balance at end of period (in USD)		$ 158,398	$ 149,386

Stock-based Compensation - Narr

Stock-based Compensation - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Aug. 31, 2021	Jul. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized (in shares)							13,700,000
Stock-based compensation expense		$ 1.1	$ 1	$ 3.4	$ 2.1
Share-based compensation, nonvested awards, compensation cost not yet recognized		$ 7.4		$ 7.4
Period for recognition of compensation on unvested stock option (in years)				1 year 9 months 18 days
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized (in shares)						1,250,000
ESPP | Employee Stock Purchase Plan 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Discount from market price, purchase date (as a percent)	15%
Purchase period (in month)	6 months
ESPP purchase price of common stock, percent of closing price (as a percent)	85%
Shares issued (in shares)				564,233

Earnings Per Share - Basic and

Earnings Per Share - Basic and diluted earnings per share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Basic weighted-average number of shares of common stock outstanding (in shares)	52,400	51,583	52,077	51,323
Effect of dilutive options, restricted stock and restricted stock units (in shares)	0	0	0	0
Diluted weighted-average number of shares of common stock outstanding (in shares)	52,400	51,583	52,077	51,323

Earnings Per Share - Weighted a

Earnings Per Share - Weighted average number of shares that could dilute basic EPS (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Convertible Preferred Stock
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	33,324	31,242	32,731	30,955
Stock options
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,555	1,446	1,526	1,114
Restricted stock awards and restricted stock units
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	5,165	3,790	4,633	3,214

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Effective tax rate	(13.10%)	20.40%	9.30%	(35.60%)

Segment Information (Details)

Segment Information (Details) - segment	3 Months Ended	9 Months Ended		12 Months Ended
	Dec. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Segment Reporting [Abstract]
Number of reportable segments	1		2
Number of operating segments		1		1

Commitment and Contingencies (D

Commitment and Contingencies (Details) - Unfavorable regulatory action $ in Millions	Oct. 14, 2019 USD ($)
Loss Contingencies [Line Items]
Damages awarded	$ 31.1
Reduction of damages awarded	$ 18

Fair Value Measurements - Finan

Fair Value Measurements - Financial Instruments Measured on a Recurring Basis (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Performance Based Phantom Shares
Financial instruments measured at fair value on a recurring basis
Grant date fair value (in USD per share)	$ 1.70
Risk-free interest rate	0.27%
Expected life (years)	2 years 8 months 15 days
Estimated volatility factor	65.80%
Expected dividends	$ 0
Liability-classified stock compensation | Fair Value, Inputs, Level 3
Financial instruments measured at fair value on a recurring basis
Fair value of liability	168,000
Liability-classified stock compensation | Recurring | Fair Value, Inputs, Level 3
Financial instruments measured at fair value on a recurring basis
Fair value of liability	$ 168,000	$ 241,000

Fair Value Measures and Disclos

Fair Value Measures and Disclosures - Narrative (Details) $ in Millions	Sep. 30, 2022 USD ($)
Term loan
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of debt	$ 255.2

Fair Value Measurements - Chang

Fair Value Measurements - Changes of Level 3 Financial Instruments (Details) - Liability-classified stock compensation - Fair Value, Inputs, Level 3 $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Stock compensation activity	$ (73)
Balance, ending period	168
Recurring
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	241
Balance, ending period	$ 168

Other Income (Expense) (Details

Other Income (Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Other (expense) income	$ (35)	$ (299)	$ 479	$ 14,053